These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11681514)

  • 21. Low-dose tamoxifen retinopathy.
    Chang T; Gonder JR; Ventresca MR
    Can J Ophthalmol; 1992 Apr; 27(3):148-9. PubMed ID: 1586887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrophysiological findings in paraneoplastic retinopathy.
    Matsui Y; Mehta MC; Katsumi O; Brodie SE; Hirose T
    Graefes Arch Clin Exp Ophthalmol; 1992; 230(4):324-8. PubMed ID: 1505762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [ERG diagnosis and differential diagnosis: results of examination over 6 years].
    Stemeyer G; Stähli P
    Klin Monbl Augenheilkd; 1996 May; 208(5):306-10. PubMed ID: 8766035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multifocal ERG in chloroquine retinopathy: regional variance of retinal dysfunction.
    Kellner U; Kraus H; Foerster MH
    Graefes Arch Clin Exp Ophthalmol; 2000 Jan; 238(1):94-7. PubMed ID: 10664060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Multifocal electroretinogram (MF-ERG) in diagnosis of macular changes. Example: senile macular degeneration].
    Palmowski AM; Sutter EE; Bearse MA; Fung W
    Ophthalmologe; 1999 Mar; 96(3):166-73. PubMed ID: 10234964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of hydroxychloroquine retinopathy with multifocal electroretinography.
    So SC; Hedges TR; Schuman JS; Quireza ML
    Ophthalmic Surg Lasers Imaging; 2003; 34(3):251-8. PubMed ID: 12757106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TAMOXIFEN RETINOPATHY DURING TREATMENT OF AN INOPERABLE DESMOID TUMOR.
    Furst M; Somogyi MB; Wong RW; Araujo D; Harper CA
    Retin Cases Brief Rep; 2020; 14(3):268-270. PubMed ID: 29227350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Senile panretinal cone dysfunction in age-related macular degeneration (AMD): a report of 52 amd patients compared to age-matched controls.
    Ronan S; Nusinowitz S; Swaroop A; Heckenlively JR
    Trans Am Ophthalmol Soc; 2006; 104():232-40. PubMed ID: 17471344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retinal changes associated with tamoxifen treatment for breast cancer.
    Tang R; Shields J; Schiffman J; Li H; Locher D; Hampton J; Prager T; Pardo G
    Eye (Lond); 1997; 11 ( Pt 3)():295-7. PubMed ID: 9373465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tamoxifen retinopathy in a male patient.
    Yanyali AC; Freund KB; Sorenson JA; Slakter JS; Wheatley HM
    Am J Ophthalmol; 2001 Mar; 131(3):386-7. PubMed ID: 11239879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Retinal damage by (hydroxy)chloroquine intake: published evidence for an efficient ophthalmological follow-up].
    Pluta JP; Rüther K
    Klin Monbl Augenheilkd; 2009 Nov; 226(11):891-6. PubMed ID: 19916149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Role of mf-ERG in the Diagnosis and Treatment of Age-Related Macular Degeneration: Electrophysiological Features of AMD.
    Moschos MM; Nitoda E
    Semin Ophthalmol; 2018; 33(4):461-469. PubMed ID: 28328288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alström syndrome--a case report and literature review.
    Karska-Basta I; Kubicka-Trzaska A; Filemonowicz-Skoczek A; Romanowska-Dixon B; Kobylarz J
    Klin Oczna; 2008; 110(4-6):188-92. PubMed ID: 18655459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subclinical maculopathy and retinopathy in transcobalamin deficiency: a 10-year follow-up.
    Rigaudière F; Nasser H; Delouvrier E; Milani P; Schiff M
    Doc Ophthalmol; 2022 Feb; 144(1):53-65. PubMed ID: 34491492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ERG campimetry using a multi-input stimulation technique for mapping of retinal function in the central visual field.
    Kretschmann U; Rüther K; Usui T; Zrenner E
    Ophthalmic Res; 1996; 28(5):303-11. PubMed ID: 8979279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of paraneoplastic visual loss with intravenous immunoglobulin: report of 3 cases.
    Guy J; Aptsiauri N
    Arch Ophthalmol; 1999 Apr; 117(4):471-7. PubMed ID: 10206574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A possible early sign of hydroxychloroquine macular toxicity.
    Brandao LM; Palmowski-Wolfe AM
    Doc Ophthalmol; 2016 Feb; 132(1):75-81. PubMed ID: 26792426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multifocal electroretinography, color discrimination and ocular toxicity in tamoxifen use.
    Salomão SR; Watanabe SE; Berezovsky A; Motono M
    Curr Eye Res; 2007 Apr; 32(4):345-52. PubMed ID: 17453956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Refractory Tamoxifen-Induced Keratopathy Despite Drug Withdrawal.
    Andreanos K; Oikonomakis K; Droutsas K; Petrelli M; Kymionis G
    Cornea; 2017 Mar; 36(3):377-378. PubMed ID: 27918356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bull's-eye maculopathy and negative electroretinogram.
    Miyake Y; Shiroyama N; Horiguchi M; Saito A; Yagasaki K
    Retina; 1989; 9(3):210-5. PubMed ID: 2595114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.